Telix Expands Prostate Cancer Activity with GenesisCare Collaboration
Go back to Telix Expands Prostate Cancer Activity with GenesisCare Collaboration| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.83 -1 (7.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.83 | 52 Week High | $2.18 | |||
| Open | $12.22 | 52 Week Low | $0.30 | |||
| Day High | $12.22 | P/E | N/A | |||
| Day Low | $11.63 | EPS | $-3.32 | |||
| Volume | 642,226 | |||||
